✦ LIBER ✦

Cell-free DNA as a Biomarker of Residual Disease Following Radiation Therapy for Non-small Cell Lung Cancer

✍ Scribed by Bratman, S.V.; Eclov, N.C.; Modlin, L.A.; Neal, J.; Loo, B.W.; Wu, G.; Richardson, K.; Newman, A.M.; Alizadeh, A.; Diehn, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-small cell lung cancer and PAH-DNA a

✍ Tang, D.L.; Santella, R.M.; Mayer, J.; Tsai, W-Y.; Perera, F.P. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Nuclear survivin as a biomarker for non-

✍ Lu, B; Gonzalez, A; Massion, P P; Shyr, Y; Shaktour, B; Carbone, D P; Hallahan, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

DNA Methylation biomarkers to assess the

✍ Steven A Belinsky; Joan H Schiller; Christine A Stidley 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PET Predicts Survival Following Stereota

✍ Mancini, B.R.; Giacalone, N.J.; Rutter, C.E.; Aneja, S.; Decker, R.H.; Husain, Z 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Involved-Field Radiation Therapy for Ino

✍ Rosenzweig, K. E.; Sura, S.; Jackson, A.; Yorke, E. 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 127 KB

Stereotactic Body Radiation Therapy for

✍ Chang, Joe Y.; Roth, Jack A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 283 KB